Cardiac disease in Ankylosing Spondylitis

Cardiac disease in Ankylosing Spondylitis - Cardiac disease in Ankylosing Spondylitis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON41462

Enrollment

400

Registered

2013-05-16

Start date

2014-03-17

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankylosing Spondylitis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Ankylosing Spondyilitis according to New York (1984) criteria Written informed consent Age 50-75 years

Exclusion criteria

Exclusion criteria: Malignant disease

Design outcomes

Primary

Measure	Time frame
Diastolic dysfunction will be defined as follows: mild diastolic dysfunction (stage Iimpaired relaxation). Characterized by an E/A ratio 240 ms), and IVRT (>110 ms). Em (1, Em/Am 10. Severe diastolic dysfunction (stage III restrictive filling). This stage is characterized by an overt increased E/A ratio (>2), shortened DT (10. (13,20)	—

Secondary

Measure	Time frame
Systolic dysfunction will be defined as an ejection fraction of	—

Countries

Netherlands

Outcome results